| Profile | GDS5420 / 243469_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 279.02 | 58 |
| GSM1296119 | B_lesional_pre-dose | 309.13 | 59 |
| GSM1296076 | C_lesional_pre-dose | 232.81 | 56 |
| GSM1296092 | D_lesional_pre-dose | 78.81 | 40 |
| GSM1296103 | E_lesional_pre-dose | 182.32 | 51 |
| GSM1296078 | F_lesional_pre-dose | 310.81 | 61 |
| GSM1296107 | G_lesional_pre-dose | 519.5 | 68 |
| GSM1296109 | H_lesional_pre-dose | 613.49 | 71 |
| GSM1296080 | I_lesional_pre-dose | 254.07 | 57 |
| GSM1296090 | J_lesional_pre-dose | 97.46 | 42 |
| GSM1296074 | K_lesional_pre-dose | 237.06 | 57 |
| GSM1296111 | L_lesional_pre-dose | 613.57 | 71 |
| GSM1296099 | M_lesional_pre-dose | 190.4 | 51 |
| GSM1296086 | O_lesional_pre-dose | 64.36 | 36 |
| GSM1296117 | P_lesional_pre-dose | 640.58 | 72 |
| GSM1296113 | Q_lesional_pre-dose | 772.77 | 75 |
| GSM1296096 | R_lesional_pre-dose | 182.11 | 51 |
| GSM1296105 | S_lesional_pre-dose | 214.19 | 53 |
| GSM1296098 | T_lesional_pre-dose | 361.18 | 62 |
| GSM1296101 | U_lesional_pre-dose | 129.19 | 45 |
| GSM1296121 | V_lesional_pre-dose | 377.2 | 63 |
| GSM1296088 | W_lesional_pre-dose | 232.5 | 55 |
| GSM1296082 | X_lesional_pre-dose | 101.94 | 44 |
| GSM1296115 | Y_lesional_pre-dose | 436.34 | 65 |
| GSM1296084 | Z_lesional_pre-dose | 226.34 | 55 |
| GSM1296072 | B_lesional_day8 | 302.19 | 59 |
| GSM1296069 | L_lesional_day8 | 710.95 | 74 |
| GSM1296071 | P_lesional_day8 | 640.77 | 72 |
| GSM1296070 | Y_lesional_day8 | 679.74 | 73 |
| GSM1296073 | V_lesional_day8 | 328.57 | 61 |
| GSM1296034 | A_lesional_day15 | 339 | 60 |
| GSM1296041 | G_lesional_day15 | 589.93 | 71 |
| GSM1296035 | R_lesional_day15 | 181.5 | 51 |
| GSM1296038 | U_lesional_day15 | 273.09 | 57 |
| GSM1296047 | B_lesional_day15 | 421.96 | 65 |
| GSM1296039 | E_lesional_day15 | 112.66 | 44 |
| GSM1296042 | H_lesional_day15 | 543.61 | 69 |
| GSM1296043 | L_lesional_day15 | 767.35 | 75 |
| GSM1296037 | M_lesional_day15 | 204.48 | 52 |
| GSM1296046 | P_lesional_day15 | 743.04 | 74 |
| GSM1296044 | Q_lesional_day15 | 717.9 | 74 |
| GSM1296045 | Y_lesional_day15 | 652.01 | 72 |
| GSM1296025 | C_lesional_day15 | 552.16 | 69 |
| GSM1296033 | D_lesional_day15 | 169.43 | 50 |
| GSM1296027 | I_lesional_day15 | 74.08 | 39 |
| GSM1296032 | J_lesional_day15 | 186.43 | 51 |
| GSM1296024 | K_lesional_day15 | 516.89 | 68 |
| GSM1296031 | W_lesional_day15 | 270.03 | 56 |
| GSM1296028 | X_lesional_day15 | 146.78 | 48 |
| GSM1296029 | Z_lesional_day15 | 153.69 | 48 |
| GSM1296026 | F_lesional_day15 | 483.17 | 68 |
| GSM1296030 | O_lesional_day15 | 92.82 | 43 |
| GSM1296040 | S_lesional_day15 | 246.22 | 56 |
| GSM1296036 | T_lesional_day15 | 344.65 | 60 |
| GSM1296048 | V_lesional_day15 | 328.64 | 60 |
| GSM1296059 | A_lesional_day43 | 140.81 | 47 |
| GSM1296066 | G_lesional_day43 | 697.83 | 73 |
| GSM1296060 | R_lesional_day43 | 200.73 | 52 |
| GSM1296063 | U_lesional_day43 | 191.14 | 52 |
| GSM1296064 | E_lesional_day43 | 191.33 | 52 |
| GSM1296067 | H_lesional_day43 | 719.79 | 74 |
| GSM1296062 | M_lesional_day43 | 127.98 | 45 |
| GSM1296068 | Q_lesional_day43 | 774.89 | 75 |
| GSM1296050 | C_lesional_day43 | 541.72 | 69 |
| GSM1296057 | D_lesional_day43 | 89.19 | 40 |
| GSM1296052 | I_lesional_day43 | 136.97 | 48 |
| GSM1296054 | J_lesional_day43 | 301.56 | 58 |
| GSM1296049 | K_lesional_day43 | 341.57 | 61 |
| GSM1296055 | W_lesional_day43 | 255.64 | 56 |
| GSM1296053 | X_lesional_day43 | 177.68 | 50 |
| GSM1296058 | Z_lesional_day43 | 111.1 | 44 |
| GSM1296051 | F_lesional_day43 | 222.4 | 55 |
| GSM1296056 | O_lesional_day43 | 89.96 | 41 |
| GSM1296065 | S_lesional_day43 | 197.32 | 52 |
| GSM1296061 | T_lesional_day43 | 359.79 | 61 |
| GSM1296095 | A_non-lesional_pre-dose | 218.27 | 54 |
| GSM1296120 | B_non-lesional_pre-dose | 459.26 | 66 |
| GSM1296077 | C_non-lesional_pre-dose | 677.63 | 73 |
| GSM1296093 | D_non-lesional_pre-dose | 231.79 | 54 |
| GSM1296104 | E_non-lesional_pre-dose | 115.97 | 44 |
| GSM1296079 | F_non-lesional_pre-dose | 393.43 | 64 |
| GSM1296108 | G_non-lesional_pre-dose | 717.74 | 74 |
| GSM1296110 | H_non-lesional_pre-dose | 1223.09 | 83 |
| GSM1296081 | I_non-lesional_pre-dose | 56.51 | 35 |
| GSM1296091 | J_non-lesional_pre-dose | 176.47 | 51 |
| GSM1296075 | K_non-lesional_pre-dose | 501.86 | 69 |
| GSM1296112 | L_non-lesional_pre-dose | 771.97 | 75 |
| GSM1296100 | M_non-lesional_pre-dose | 134.45 | 45 |
| GSM1296087 | O_non-lesional_pre-dose | 123.76 | 47 |
| GSM1296118 | P_non-lesional_pre-dose | 793.51 | 75 |
| GSM1296114 | Q_non-lesional_pre-dose | 1158.16 | 82 |
| GSM1296097 | R_non-lesional_pre-dose | 223.76 | 54 |
| GSM1296106 | S_non-lesional_pre-dose | 365.2 | 62 |
| GSM1296102 | U_non-lesional_pre-dose | 246.14 | 55 |
| GSM1296122 | V_non-lesional_pre-dose | 395.63 | 63 |
| GSM1296089 | W_non-lesional_pre-dose | 366.07 | 62 |
| GSM1296083 | X_non-lesional_pre-dose | 206.35 | 53 |
| GSM1296116 | Y_non-lesional_pre-dose | 912.82 | 78 |
| GSM1296085 | Z_non-lesional_pre-dose | 168.7 | 50 |